During the past decade, Mangala Hospital & Mangala Kidney Foundation conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mangala Hospital & Mangala Kidney Foundation" are "Migraine" (3 trials), "Episodic Migraine" (2 trials), "Chronic Migraine" (1 trials), "Epilepsy, Partial Seizures" (1 trials) and "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials). Many other conditions were trialed in "Mangala Hospital & Mangala Kidney Foundation" in a lesser frequency.

Most popular intervention types in "Mangala Hospital & Mangala Kidney Foundation" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Galcanezumab" (3 trials), "Lasmiditan" (3 trials), "Pregabalin" (1 trials) and "Pregabalin Dose Level 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mangala Hospital & Mangala Kidney Foundation" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Mangala Hospital & Mangala Kidney Foundation". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mangala Hospital & Mangala Kidney Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mangala Hospital & Mangala Kidney Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".